Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPhoenix Group Holdings Regulatory News (PHNX)

  • There is currently no data for PHNX

Deleveraging Programme Update

20 Jun 2024 07:00

RNS Number : 1271T
Phoenix Group Holdings PLC
20 June 2024
 

 

Phoenix Group Holdings plc

LEI: 2138001P49OLAEU33T68

 

Phoenix Group deleveraging programme update

 

The Board of Phoenix Group Holdings plc ("Phoenix Group" or "the Group") is pleased to announce the completion of the initial phase of its deleveraging programme, comprising a debt redemption and refinancing exercise.

This is in support of the Group's stated deleveraging programme, where it intends to repay at least £500 million of debt and is targeting a Solvency II leverage ratio of c.30% by the end of 2026.

On 3 May 2024 the Group announced that it would fully redeem its £250 million Tier 2 notes due 2029 on their first call date of 13 June 2024, which have now been fully repaid.

The Group has also prudently chosen to re-finance $500 million of its outstanding Restricted Tier 1 ("RT1") notes callable in early 2025 through a tender exercise, and successfully issued $500 million of new RT1 notes at a $ coupon of 8.5%.

The Group has therefore reduced its outstanding debt by £250 million, with its annual debt interest costs broadly unchanged after this redemption and refinancing exercise. As a result, the Group maintains its strong cash interest cover of c.6 times.


Enquiries

Investors/analysts:

Claire Hawkins, Director of Corporate Affairs and Investor Relations, Phoenix Group

+44 (0)20 4559 3161

Andrew Downey, Investor Relations Director, Phoenix Group

+44 (0)20 4559 3145

Media:

Douglas Campbell, Teneo

+44 (0)7753 136 628

Shellie Wells, Corporate Communications Director, Phoenix Group

+44 (0)20 4559 3031


Legal Disclaimers

This announcement in relation to Phoenix Group Holdings plc and its subsidiaries (the 'Group') contains, and the Group may make other statements (verbal or otherwise) containing, forward-looking statements and other financial and/or statistical data about the Group's current plans, goals, ambitions, outlook, guidance and expectations relating to future financial condition, performance, results, strategy and/or objectives.

Statements containing the words: 'believes', 'intends', 'will', 'may', 'should', 'expects', 'plans', 'aims', 'seeks', 'targets', 'continues' and 'anticipates' or other words of similar meaning are forward looking. Such forward-looking statements and other financial and/or statistical data involve risk and uncertainty because they relate to future events and circumstances that are beyond the Group's control. For example, certain insurance risk disclosures are dependent on the Group's choices about assumptions and models, which by their nature are estimates. As such, actual future gains and losses could differ materially from those that the Group has estimated.

Other factors which could cause actual results to differ materially from those estimated by forward-looking statements include, but are not limited to: domestic and global economic, political, social, environmental and business conditions; asset prices; market related risks such as fluctuations in investment yields, interest rates and exchange rates, the potential for a sustained low-interest rate or high-interest rate, environment, and the performance of financial or credit markets generally; the policies and actions of governmental and/or regulatory authorities, including, for example, initiatives related to the financial crisis, the COVID-19 pandemic, climate change and the effect of the UK's version of the "Solvency II" regulations on the Group's capital maintenance requirements; the impact of changing inflation rates (including high inflation) and/or deflation; the medium and long-term political, legal, social and economic effects of the COVID-19 pandemic and the UK's exit from the European Union; the direct and indirect consequences of the European and global macroeconomic conditions of the Russia-Ukraine War and related or other geopolitical conflicts; information technology or data security breaches (including the Group being subject to cyberattacks); the development of standards and interpretations including evolving practices in ESG and climate reporting with regard to the interpretation and application of accounting; the limitation of climate scenario analysis and the models that analyse them; lack of transparency and comparability of climate-related forward-looking methodologies; climate change and a transition to a low-carbon economy (including the risk that the Group may not achieve its targets); market competition; changes in assumptions in pricing and reserving for insurance business (particularly with regard to mortality and morbidity trends, gender pricing and lapse rates); the timing, impact and other uncertainties of proposed or future acquisitions, disposals or combinations within relevant industries; risks associated with arrangements with third parties; inability of reinsurers to meet obligations or unavailability of reinsurance coverage; the impact of changes in capital, and implementing changes in IFRS 17 or any other regulatory solvency and/or accounting standards, and tax and other legislation and regulations in the jurisdictions in which members of the Group operate.

As a result, the Group's actual future financial condition, performance and results may differ materially from the plans, goals, ambitions, outlook, guidance and expectations set out in the forward-looking statements and other financial and/or statistical data within this announcement. The Group undertakes no obligation to update any of the forward-looking statements or data contained within this announcement or any other forward-looking statements or data it may make or publish. Nothing in this announcement constitutes, nor should it be construed as, a profit forecast or estimate.

This announcement does not constitute an offer to sell or the solicitation of an offer to buy securities in the United States or in any other jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration, exemption from registration or qualification under the securities law of any such jurisdiction. The securities referred to above have not been, and will not be, registered under the U.S. Securities Act of 1933, as amended (the "Securities Act") or under any relevant securities laws of any state of the United States and may not be offered or sold to U.S. persons or to persons within the United States, except pursuant to an exemption from the Securities Act.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDEAXKNFEFLEFA
Date   Source Headline
31st Jan 20222:00 pmRNSTotal Voting Rights
28th Jan 20227:09 amRNSStrategic Investor Update
18th Jan 20226:00 pmRNSHolding(s) in Company
18th Jan 20226:00 pmRNSHolding(s) in Company
17th Jan 20221:00 pmRNSDirector/PDMR Shareholding
14th Jan 20225:00 pmRNSHolding(s) in Company
12th Jan 20227:00 amRNSResult of Secondary Placing in Phoenix Group Hldgs
11th Jan 20225:09 pmRNSProposed Secondary Placing in Phoenix Group Hldgs
11th Jan 20227:00 amRNS2021 Bulk Purchase Annuity Transactions
7th Jan 20222:30 pmRNSDirector/PDMR Shareholding
31st Dec 202112:00 pmRNSTotal Voting Rights
30th Dec 20214:30 pmRNSDirector/PDMR Shareholding
22nd Dec 202112:00 pmRNSChange of Auditor
20th Dec 20211:00 pmRNSBlock listing Interim Review
10th Dec 20214:00 pmRNSDirector/PDMR Shareholding
30th Nov 20212:15 pmRNSTotal Voting Rights
9th Nov 202110:15 amRNSDirector/PDMR Shareholding
1st Nov 20214:52 pmRNSArk Life Assurance Sale Completion
29th Oct 20214:30 pmRNSTotal Voting Rights
8th Oct 20219:30 amRNSDirector/PDMR Shareholding
30th Sep 20215:00 pmRNSTotal Voting Rights
27th Sep 202111:00 amRNSDirector/PDMR Shareholding
14th Sep 20212:07 pmRNSInternal Model Harmonisation Approval
8th Sep 20214:15 pmRNSDirector/PDMR Shareholding
8th Sep 20214:15 pmRNSDirector/PDMR Shareholding
1st Sep 202110:00 amRNSTotal Voting Rights
25th Aug 202112:00 pmRNSDirector/PDMR Shareholding
20th Aug 202111:45 amRNSDirector/PDMR Shareholding
20th Aug 202111:45 amRNSDirector/PDMR Shareholding
16th Aug 202112:00 pmRNSDirector/PDMR Shareholding
12th Aug 20214:00 pmRNSDirector/PDMR Shareholding
11th Aug 20217:00 amRNS2021 Half Year Results
9th Aug 20214:30 pmRNSDirector/PDMR Shareholding
30th Jul 202111:45 amRNSTotal Voting Rights
13th Jul 20217:00 amRNSSale of Ark Life Assurance Company
8th Jul 20214:20 pmRNSDirector/PDMR Shareholding
1st Jul 20214:00 pmRNSTotal Voting Rights
29th Jun 20214:15 pmRNSHolding(s) in Company
25th Jun 20214:00 pmRNSDirector/PDMR Shareholding
24th Jun 20215:15 pmRNSBlock listing Interim Review
23rd Jun 20215:30 pmRNSPhoenix Group Holdings
23rd Jun 20217:00 amRNSResult of Secondary Placing in Phoenix Group Hldgs
23rd Jun 20217:00 amRNSStrategic Investor Update and Board Change
22nd Jun 20214:40 pmRNSProposed Secondary Placing in Phoenix Group Hldgs
16th Jun 20213:00 pmRNSBlock Listing Application
15th Jun 202112:00 pmRNSDiscussions in Respect of Sale Discontinued
9th Jun 20218:30 amRNSDirector/PDMR Shareholding
28th May 20212:00 pmRNSTotal Voting Rights
20th May 20214:00 pmRNSDirector/PDMR Shareholding
18th May 20217:00 amRNSStatement in Response to Press Speculation

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.